Molecule intelOpportunity: Lower0

Mirtazapine

33 brands · 27 companies · product forms

Opportunity snapshot

Launch attractiveness
28
Market saturation
70
Price room
91
Regulatory risk
0
33
brands
27
companies
Rs 514.78
median price
16
price points
4.65x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 6%

Price room

Across observed sources and strengths
CheapestRs 167.85
MedianRs 514.78
Most expensiveRs 780
Spread4.65×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.65x across 16 trusted points (Rs 167.85-780.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Mirtazapine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(91) + 20% low-competition(30) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

27 canonical companies and 33 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.65x across 16 trusted points (Rs 167.85-780.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.